Effect of Semaglutide on Atrial Arrhythmias Recurrence Following Ablation for Atrial Fibrillation: A Prospective Study
Semaglutide treatment following catheter ablation for atrial fibrillation is associated with a lower rate of atrial arrhythmia recurrence over 12 months and may lead to improvements in weight and glycated hemoglobin levels.
Authors
- Die Yao (ORCID: https://orcid.org/0009-0003-8021-7479)
- Mu Qin (ORCID: https://orcid.org/0000-0002-1645-4758)
- Minmin Fu (ORCID: https://orcid.org/0000-0002-7710-7290)
- x. hou
- Shiwen Wu (ORCID: https://orcid.org/0000-0003-1023-4073)
- Yu Zhang (ORCID: https://orcid.org/0000-0003-1135-3285)
- Min Chen (ORCID: https://orcid.org/0000-0003-0419-743X)
- Weifeng Jiang
- Shi‐Yi Wang (ORCID: https://orcid.org/0000-0002-3294-5784)
- Hong Yu (ORCID: https://orcid.org/0000-0002-1094-4334)
- Ziliang Song (ORCID: https://orcid.org/0000-0002-7403-5236)
- Jiongchao Guo
- Xu Liu
Institutions
- Anhui Medical University (CN)
- Shanghai Chest Hospital (CN)
- World Wide Web Consortium (US)
- Anhui Provincial Hospital (CN)
- First Affiliated Hospital of Anhui Medical University (CN)
- Third People's Hospital of Hefei (CN)
Publication Details
- Journal
- Circulation Arrhythmia and Electrophysiology
- Published
- 2025-10-09
- DOI
- https://doi.org/10.1161/circep.125.014069
- Citations
- 4
- Primary Topic
- Atrial Fibrillation Management and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 5.55